ABO-401 Gene Therapy Shows Potential to Restore CFTR Function in Preclinical Study
ABO-401
Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual Meeting
https://www.biospace.com/article/abeona-therapeutics-to-report-new-preclinical-data-demonstrating-therapeutic-potential-of-abo-401-for-treatment-of-cystic-fibrosis-at-american-society-of-gene-and-cell-therapy-annual-meeting/
